Originally published in Pharmaceutical Tech Magazine
The pharmaceutical cold chain has become increasingly complex as biologics, cell and gene therapies, vaccines, and temperature-sensitive specialty medicines make up a larger share of the global market. Because these products require tightly controlled storage, transportation, and handling conditions throughout the supply chain, even minor disruptions can compromise product quality, delay patient access, and increase financial risk.
While much attention rightly focuses on maintaining product integrity, the financial processes supporting cold chain operations also deserve equal consideration. An inefficient order-to-cash (O2C) process can create billing disputes, payment delays, compliance challenges, and revenue leakages that erode profitability even when products reach customers successfully.
As investment in digital supply chains grows, improving financial workflows alongside logistics has become essential.
Read the full article in Pharmaceutical Tech Magazine >
About the Author
